A Study of CS1003 in Subjects With Advanced Solid Tumors

Clinical trial NCT03475251 · COMPLETED

Trial details

NCT number: NCT03475251
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2018-05-09
Primary completion: 2021-05-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.